$CRNX stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $47,870,230 of trading volume.
It has been the 289th most-searched ticker on Quiver Quantitative over the last day, out of 10,168 total tickers searched.
Here is what we see in our data on $CRNX (you can track the company live on Quiver's $CRNX stock page):
$CRNX Insider Trading Activity
$CRNX insiders have traded $CRNX stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $CRNX stock by insiders over the last 6 months:
- DANA PIZZUTI (Chief Med and Dev Officer) has made 0 purchases and 7 sales selling 56,492 shares for an estimated $1,910,298.
- MATTHEW K FUST sold 16,000 shares for an estimated $716,000
- RICHARD SCOTT STRUTHERS (President & CEO) sold 4,000 shares for an estimated $180,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CRNX Hedge Fund Activity
We have seen 127 institutional investors add shares of $CRNX stock to their portfolio, and 141 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 2,574,683 shares (+44.3%) to their portfolio in Q3 2025, for an estimated $107,235,546
- FARALLON CAPITAL MANAGEMENT LLC added 1,124,000 shares (+24.2%) to their portfolio in Q3 2025, for an estimated $46,814,600
- STATE STREET CORP removed 1,016,599 shares (-31.5%) from their portfolio in Q3 2025, for an estimated $42,341,348
- JPMORGAN CHASE & CO added 926,765 shares (+279.2%) to their portfolio in Q3 2025, for an estimated $38,599,762
- VESTAL POINT CAPITAL, LP removed 750,000 shares (-50.0%) from their portfolio in Q3 2025, for an estimated $31,237,500
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 655,588 shares (-91.5%) from their portfolio in Q3 2025, for an estimated $27,305,240
- FRANKLIN RESOURCES INC removed 628,738 shares (-96.9%) from their portfolio in Q3 2025, for an estimated $26,186,937
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRNX Analyst Ratings
Wall Street analysts have issued reports on $CRNX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 11/07/2025
- Oppenheimer issued a "Outperform" rating on 09/30/2025
- Leerink Partners issued a "Outperform" rating on 09/29/2025
- JMP Securities issued a "Market Outperform" rating on 09/26/2025
- Baird issued a "Outperform" rating on 09/26/2025
- JP Morgan issued a "Overweight" rating on 09/24/2025
- HC Wainwright & Co. issued a "Buy" rating on 06/27/2025
To track analyst ratings and price targets for $CRNX, check out Quiver Quantitative's $CRNX forecast page.
$CRNX Price Targets
Multiple analysts have issued price targets for $CRNX recently. We have seen 9 analysts offer price targets for $CRNX in the last 6 months, with a median target of $81.0.
Here are some recent targets:
- Jonathan Wolleben from Citizens set a target price of $108.0 on 11/07/2025
- Leland Gershell from Oppenheimer set a target price of $87.0 on 09/30/2025
- Jeffrey Hung from Morgan Stanley set a target price of $77.0 on 09/29/2025
- Joseph Schwartz from Leerink Partners set a target price of $88.0 on 09/29/2025
- Jonathan Wolleben from JMP Securities set a target price of $143.0 on 09/26/2025
- Brian Skorney from Baird set a target price of $62.0 on 09/26/2025
- Richard Law from Goldman Sachs set a target price of $40.0 on 09/26/2025
You can track data on $CRNX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
